Two members of Congress — Rep. Elijah Cummings (D-Md.) and Sen. Bernie Sanders (I-Vt.) — have asked three generic drug makers for documents as part of an investigation into price hikes, renewing an effort the lawmakers first began in 2014.
In letters to Mylan (MYL), Teva Pharmaceutical (TEVA), and Heritage Pharmaceuticals, Cummings and Sanders also asked for information about allegations the companies apparently attempted to “stonewall” their 2014 probe (read the letters here, here, and here). The allegations surfaced this past May in a price-fixing lawsuit that was filed by 44 state attorneys general against 20 generic drug makers.
About the Author Reprints
